A clinical observation of Chinese chronic myelogenous leukemia patients after discontinuation of tyrosine kinase inhibitors

Whether tyrosine kinase inhibitors (TKIs) can be safely discontinued is a key focus of chronic myelogenous leukemia (CML) at present. We report a clinical observation of TKIs cessation in Chinese CML patients and a probable connection between CML leukemia stem cells (LSCs) and relapse. In all, 22 of...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qing, Zhong, Zhaodong, Zeng, Chen, Meng, Li, Li, Chunrui, Luo, Yi, Wang, Hongxiang, Li, Weiming, Wang, Jue, Cheng, Fanjun, Guo, Anyuan, Liu, Songya, Jin, Caibao, Zhu, Xiaojian, You, Yong, Zou, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295427/
https://www.ncbi.nlm.nih.gov/pubmed/27533462
http://dx.doi.org/10.18632/oncotarget.11281

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295427/
https://www.ncbi.nlm.nih.gov/pubmed/27533462
http://dx.doi.org/10.18632/oncotarget.11281

Ejemplares similares